12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Other News

AstraZeneca, Medical Research Council (MRC), MRC Mammalian Genetics Unit Harwell, Imperial College London, Royal Veterinary College, University of Birmingham, U

The MRC awarded £7 million ($11.3 million) in funding for 15 research projects to the universities and institutes to evaluate compounds provided by AstraZeneca. MRC said the disease areas include Alzheimer's disease, cancer, lung disease, motor neuron disease and muscular dystrophies. Eight of the projects will involve clinical trials...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >